Royalty Pharma plc
RPRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001802768
In the last 90 days, Royalty Pharma plc insiders filed 0 open-market purchases and 5 sales; 650 institutions reported holding it in 13F filings for Q2 2026, worth $20.6B in total; Dorsey Asset Management is the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Royalty Pharma plc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 5 filings
- 3 insiders, $20.3M in total
- Insiders trading
- 3
- Net value
- −$20.3M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Royalty Pharma plc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Hite Christopher | EVP & Chairman, Partnering | 270,401Indirect | Sep 24, 2026 | 8 |
| Coyne Terrance P. | EVP & CFO | 0Indirect | Aug 17, 2026 | 18 |
| Legorreta Pablo G. | CEO, Chairman of the Board | 1,307,820 | Aug 7, 2026 | 4 |
| Urist Marshall | EVP, Research & Investments | 8,252 | Aug 7, 2026 | 18 |
| Bassler Bonnie L | Director | 79,181 | Jun 30, 2026 | 5 |
| Weatherman Elizabeth H | Director | 13,103 | Jun 8, 2026 | 1 |
| Love Ted W | Director | 58,393 | Jun 8, 2026 | 1 |
| Hodgson David C | Director | 37,873 | Jun 8, 2026 | 1 |
| Norden Gregory | Director | 196,348 | Jun 8, 2026 | 2 |
| Coric Vlad | Director | 15,343 | Jun 8, 2026 | 1 |
| Ho Carole | Director | 4,545 | Jun 8, 2026 | 1 |
| Engelbert Catherine M. | Director | 55,673 | Jun 8, 2026 | 1 |
| Lloyd George W. | EVP, Investments & CLO | 0Indirect | Dec 19, 2025 | 4 |
| Fernandez Henry A | Director | 65,324 | Jun 30, 2025 | 0 |
| Desouza Errol B | Director | 81,352 | May 14, 2025 | 0 |
| Riggs Rory B | Director | 320,099 | Feb 22, 2024 | 0 |
| Giuliani Mario Germano | Director, 10% Owner | 2,477,520Indirect | Jan 3, 2024 | 0 |
| Avara Management Ltd | 10% Owner | 2,477,520Indirect | Jan 3, 2024 | 0 |
| Skyeline Management Ltd | 10% Owner | 7,795,072Indirect | Dec 7, 2022 | 0 |
| MGG Strategic SICAF SIF S.A. - MGG Strategic | 10% Owner | 7,879,374Indirect | Dec 5, 2022 | 0 |
| MGG Strategic SICAF SIF S.A. | 10% Owner | 7,879,374Indirect | Dec 5, 2022 | 0 |
| Reddoch James F. | EVP & Chief Scientific Officer | 820,800Indirect | Sep 30, 2022 | 0 |
| GG 1978 Sicaf Sif S.A. - GG Strategic | 10% Owner | 21,426,170Indirect | Sep 22, 2022 | 0 |
| GG 1978 Sicaf Sif S.A. | 10% Owner | 21,426,170Indirect | Sep 22, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2021 (view filing) | Nov 16-17 | 2 days | Lloyd George W.EVP, Investments & GC | SSaleClass A Ordinary Shares | −250.0K | $42.39 | −$10.6M | −28.4%630.0K after | 4 lots |
| Nov 18, 2021 (view filing) | Nov 16-17 | 2 days | Riggs Rory BDirector | SSaleClass A Ordinary Shares | −75.0K | $42.33 | −$3.17M | −10.8%622.4K after | 2 lots |
| Nov 18, 2021 (view filing) | Nov 17 | 1 day | Riggs Rory BDirector | SSaleClass A Ordinary Shares | −139.4K | $42.35 | −$5.90M | −11.1%1.12M after | 3 lots |
| Sep 30, 2021 (view filing) | Sep 28-29 | 2 days | Riggs Rory BDirector | SSaleClass A Ordinary Shares | −64.6K | $36.65 | −$2.37M | −9.5%615.1K after | 2 lots |
| Sep 30, 2021 (view filing) | Sep 29 | 1 day | Riggs Rory BDirector | SSaleClass A Ordinary Shares | −63.8K | $36.35 | −$2.32M | −3.0%2.07M after | 3 lots |
| Jul 27, 2021 (view filing) | Jul 26 | 1 day | Lloyd George W.EVP, Investments & GC | SSaleClass A Ordinary Shares | −13.4K | $39.78 | −$531.5K | −1.7%780.0K after | 2 lots |
| Jul 27, 2021 (view filing) | Jul 26 | 1 day | Reddoch James F.EVP, Research & Investments | SSaleClass A Ordinary Shares | −8.95K | $39.78 | −$356.0K | −0.8%1.17M after | Duplicate filing |
| Jul 27, 2021 (view filing) | Jul 26 | 1 day | Reddoch James F.EVP, Research & Investments | SSaleClass A Ordinary Shares | −8.95K | $39.78 | −$356.0K | −0.8%1.17M after | |
| Jul 14, 2021 (view filing) | Jul 12-13 | 2 days | Lloyd George W.EVP, Investments & GC | SSaleClass A Ordinary Shares | −23.1K | $42.01 | −$972.5K | −2.9%788.4K after | 3 lots |
| Jul 14, 2021 (view filing) | Jul 12-14 | 2 days | Reddoch James F.EVP, Research & Investments | SSaleClass A Ordinary Shares | −17.9K | $42.01 | −$753.4K | −1.5%1.18M after | 3 lots |
| Jul 8, 2021 (view filing) | Jul 6-8 | 2 days | Reddoch James F.EVP, Research & Investments | SSaleClass A Ordinary Shares | −73.1K | $42.19 | −$3.09M | −5.8%1.20M after | 3 lots |
| Jul 8, 2021 (view filing) | Jul 6-8 | 2 days | Lloyd George W.EVP, Investments & GC | SSaleClass A Ordinary Shares | −88.5K | $42.20 | −$3.73M | −9.9%806.5K after | 6 lots |